Defining Solutions
At IVI, our programs bring together stakeholders to focus on some of the most demanding questions in healthcare so we can find solutions that advance better patient outcomes.
HTA Innovation
Innovation in health technologies (pharmaceutical and non-pharmaceutical) has made major contributions to improved life expectancy and quality of life in past decades…
Health Equity
Historically, many patient communities are underrepresented in research and have been left out of the development of measures and methods for HTA.
Economic Impact
The health economic burden on individuals in the United States is significant. Americans owe nearly $195 million in medical debt, and these financial burdens are worse for middle-aged and BIPOC individuals (Black, Indigenous, People of Color).
Rare Diseases
More than 30 million Americans are living with rare diseases and disorders.
One study estimated the total economic burden in the US of 379 rare diseases to be $997 billion in 2019.
HTA Models
The Open-Source Value Project is a laboratory for advancing the science and improving the practice of value assessment in the U.S.
RESOURCES
A research-based plan for putting the principle of patient-centricity into practice